2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Speakers - CRDWC 2025

Cai Ligang, Cancer R&D World Conference, Boston, Massachusetts, USA

Cai Ligang

Cai Ligang

  • Designation: Wuhan Boweid Biotechnology Co. Ltd
  • Country: China

Biography

Dr. Cai is Doctor of Medicine from Tongji Medical College, Huazhong University of Science and Technology. Dr. Cai began conceptualizing and designing recombinant Coxsackievirus B3 in 2010, and led a research and development team to tackle the construction, preparation process, and quality standards of recombinant Coxsackievirus B3, making recombinant Coxsackievirus B3 injection a potent anti-tumor drug and providing new directions for the development and utilization of oncolytic drugs.